<DOC>
	<DOCNO>NCT02965664</DOCNO>
	<brief_summary>A study Establish Safety , Tolerability , Efficacy PresbiDrops ( CSF-1 ) Presbyopic Subjects .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy PresbiDrops ( CSF-1 ) Presbyopic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Presbyopia</mesh_term>
	<criteria>1 . Men woman 40 65 year age ( inclusive ) 2 . Subjects provide write informed consent participate study 3 . Subjects sign presbyopia upon ophthalmic examination 4 . Subjects normal presbyopia distance correction distance refraction , within limit : sphere +3 Dioptres 3 Dioptres , cylinder great Â± 0.75 DC ( base subjective refraction test ) 5 . Subjects must best correct vision least 20/20 eye , currently depend read glass bifocals near addition &gt; +1.00 Dioptres 6 . Subjects general good health opinion Investigator determine medical history 7 . Women childbearing potential must negative urine pregnancy test Screening willing able use medically acceptable method birth control postmenopausal . Acceptable method birth control study include : vasectomy , tubal ligation , consistent use approve oral contraceptive ( birth control pill ) , intrauterine device , hormonal implant , contraceptive injection double barrier method ( diaphragm spermicidal gel condom contraceptive foam ) . Postmenopausal woman define woman menstruation cessation 12 consecutive month prior sign inform consent form . 8 . Subjects must able understand requirement study must willing comply requirement study 1 . History macular disease ocular condition congenital malformation 2 . Any medical condition know affect structure uvea , cornea , lens retina main function eye 3 . No cataract minimal nuclear sclerosis 4 . Severe dry eye 5 . Any topical ophthalmic medication , artificial tear ( maximum 4 time per day ) medication associate fluctuation accommodative capacity and/or pupil size , unless stable dose least 3 month Screening 6 . Contact lenses past three month Screening visit 7 . A difference 0.50 Dioptres manifest spherical equivalent objective refraction spherical equivalent 8 . Pupil size le 2.5 mm either eye prior dilation ambient light 815 lux prior Baseline visit 9 . A history herpes ( kind ) either eye 10 . Cataract surgery and/or refractive surgery either eye 11 . Known contraindication , hypersensitivity and/or allergy study drug excipients 12 . Any acute illness ( e.g . acute infection ) within 48 hour first study drug administration , consider significance Investigator 13 . Participation another clinical trial drug receive within 30 day Screening 14 . Pregnant currently lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>